MSLN-CAR-T-IL-2tb

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameMSLN-CAR-T-IL-2tb

Drug Alias NameIL-2tb secreting anti-mesothelin CAR T-cell therapy (Gracell Biotechnology)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionMesothelin modulatorsInterleukin-2 receptor agonists

TargetsMesothelinInterleukin-2 receptor

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesGracell Biotechnologies Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGracell Biotechnologies Inc

Active IndicationsN/A

Inactive IndicationsSolid tumours

Other Information

ATC CodeN/A